Expression and Significance of PD-1 and ICOS in Patients with Primary Immune Thrombocytopenia.
10.19746/j.cnki.issn.1009-2137.2022.04.030
- Author:
Zi FU
1
;
Wen QU
2
;
Zong-Hong SHAO
1
;
Hua-Quan WANG
1
;
Li-Min XING
1
;
Xi-Feng DONG
1
;
Zhao-Yun LIU
1
;
Xiao-Na LI
1
;
Yang ZHANG
1
;
Shao-Xue DING
1
Author Information
1. Department of Hematology, Tianjin Medical University General Hospital, Tianjin 300052, China.
2. Department of Hematology, Tianjin Medical University General Hospital, Tianjin 300052, China.E-mail: quwentj923@sina.com.
- Publication Type:Journal Article
- Keywords:
inducible costimulator;
primary immune thrombocytopenia;
programmed death receptor-1
- MeSH:
CD8-Positive T-Lymphocytes/metabolism*;
Flow Cytometry;
Humans;
Inducible T-Cell Co-Stimulator Protein/metabolism*;
Platelet Count;
Programmed Cell Death 1 Receptor/metabolism*;
Purpura, Thrombocytopenic, Idiopathic
- From:
Journal of Experimental Hematology
2022;30(4):1170-1175
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the expression of programmed death receptor-1 (PD-1) and inducible costimulator (ICOS) on the surface of CD8+ T cells in peripheral blood of patients with primary immune thrombocytopenia (ITP), and explore the roles of PD-1 and ICOS in the occurrence and development of ITP.
METHODS:A total of 28 ITP patients treated in Tianjin Medical University General Hospital from September to December 2020 were selected, including 13 patients with newly diagnosed ITP, 15 patients with chronic ITP, and 22 healthy volunteers were recruited as control group. Flow cytometry was used to detect the expression levels of PD-1 and ICOS, and evaluate their correlation with clinical indicators.
RESULTS:The percentage of CD8 + T cells in ITP patients of chronic group was higher than that of the newly diagnosed group and the control group (P<0.05). The expression level of PD-1 on CD8+ T cells in ITP patients of newly diagnosed group and chronic group were significantly lower than that of the control group (P<0.05), while the expression level of ICOS were significantly higher (P<0.05). In ITP patients, PD-1 was negatively correlated with platelet count (r=-0.4942, P<0.01), but positively with ICOS (r=0.4342). PD-1 and ICOS were both negatively correlated with lymphocyte count (rPD-1=-0.4374; rICOS=-0.4492).
CONCLUSION:In ITP patients, the unbalanced expression of PD-1 and ICOS may interfere with the immune homeostasis of the body, which can be used as a therapeutic target for ITP patients.
